Close Menu

NEW YORK – Horizon Discovery Group reported on Monday that its 2019 revenues rose nearly 8 percent year over year, thanks to growth in its research reagents and screening business units.

For the 12 months ended Dec. 31 2019, the gene editing and gene modulation technologies company reported total revenues of £58.3 million ($63.2 million), up from £54.1 million in 2018. On a constant currency basis, revenues rose nearly 5 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.